Stay updated on Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site footer revision changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T14:10:52.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The Lennox-Gastaut syndrome surveillance study record is displayed, with details about rufinamide treatment, study design, participation criteria, locations, and measured outcomes. The record also includes its registration and update history.
    Difference
    33%
    Check dated 2026-11-07T13:46:12.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:25:35.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record itself remains inaccessible and displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:57:33.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2, while the study record remains an inaccessible 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T15:45:57.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T15:49:42.000Z thumbnail image

Stay in the know with updates to Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.